Centre for Biomedical Technologies (CBT), School of Mechanical, Medical and Process Engineering, Faculty of Engineering, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
Translational Research Institute (TRI), Brisbane, QLD 4102, Australia.
Cells. 2023 Dec 23;13(1):37. doi: 10.3390/cells13010037.
Chondrogenic induction of bone-marrow-derived stromal cells (BMSCs) is typically accomplished with medium supplemented with growth factors (GF) from the transforming growth factor-beta (TGF-β)/bone morphogenetic factor (BMP) superfamily. In a previous study, we demonstrated that brief (1-3 days) stimulation with TGF-β1 was sufficient to drive chondrogenesis and hypertrophy using small-diameter microtissues generated from 5000 BMSC each. This biology is obfuscated in typical large-diameter pellet cultures, which suffer radial heterogeneity. Here, we investigated if brief stimulation (2 days) of BMSC microtissues with BMP-2 (100 ng/mL) or growth/differentiation factor (GDF-5, 100 ng/mL) was also sufficient to induce chondrogenic differentiation, in a manner comparable to TGF-β1 (10 ng/mL). Like TGF-β1, BMP-2 and GDF-5 are reported to stimulate chondrogenic differentiation of BMSCs, but the effects of transient or brief use in culture have not been explored. Hypertrophy is an unwanted outcome in BMSC chondrogenic differentiation that renders engineered tissues unsuitable for use in clinical cartilage repair. Using three BMSC donors, we observed that all GFs facilitated chondrogenesis, although the efficiency and the necessary duration of stimulation differed. Microtissues treated with 2 days or 14 days of TGF-β1 were both superior at producing extracellular matrix and expression of chondrogenic gene markers compared to BMP-2 and GDF-5 with the same exposure times. Hypertrophic markers increased proportionally with chondrogenic differentiation, suggesting that these processes are intertwined for all three GFs. The rapid action, or "temporal potency", of these GFs to induce BMSC chondrogenesis was found to be as follows: TGF-β1 > BMP-2 > GDF-5. Whether briefly or continuously supplied in culture, TGF-β1 was the most potent GF for inducing chondrogenesis in BMSCs.
骨髓基质细胞(BMSCs)的软骨诱导通常通过添加转化生长因子-β(TGF-β)/骨形态发生蛋白(BMP)超家族的生长因子(GF)的培养基来实现。在之前的研究中,我们证明了使用每个 5000 个 BMSC 生成的小直径微组织,短暂(1-3 天)刺激 TGF-β1 足以驱动软骨生成和肥大。这种生物学在典型的大直径球团培养物中是混乱的,这些培养物存在径向异质性。在这里,我们研究了短暂(2 天)刺激 BMP-2(100ng/mL)或生长/分化因子(GDF-5,100ng/mL)对 BMSC 微组织是否也足以诱导软骨分化,方式与 TGF-β1(10ng/mL)类似。与 TGF-β1 一样,BMP-2 和 GDF-5 据报道可刺激 BMSCs 的软骨分化,但在培养中短暂或短暂使用的效果尚未得到探索。肥大是 BMSC 软骨分化中不希望出现的结果,这使得工程化组织不适合用于临床软骨修复。使用三个 BMSC 供体,我们观察到所有 GF 都促进了软骨生成,尽管刺激的效率和所需的持续时间不同。与 BMP-2 和 GDF-5 相比,用 2 天或 14 天 TGF-β1 处理的微组织在产生细胞外基质和表达软骨基因标志物方面都更优越,而暴露时间相同。肥大标志物与软骨分化成比例增加,表明这三个 GF 之间存在这些过程交织在一起。这些 GF 诱导 BMSC 软骨生成的快速作用或“时间效力”如下:TGF-β1>BMP-2>GDF-5。在培养中无论是短暂还是连续供应,TGF-β1 都是诱导 BMSCs 软骨生成最有效的 GF。